Matinas Biopharma Holdings Profit Margin 2012-2020 | MTNB

Current and historical gross margin, operating margin and net profit margin for Matinas Biopharma Holdings (MTNB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Matinas Biopharma Holdings net profit margin as of March 31, 2020 is 0%.
Matinas Biopharma Holdings Annual Profit Margins
Matinas Biopharma Holdings Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.161B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.383B 41.65
Takeda Pharmaceutical (TAK) Japan $58.389B 10.18
Astellas Pharma (ALPMY) Japan $30.180B 15.29
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 21.34
Merck (MKGAF) Germany $17.008B 22.31
Catalent (CTLT) United States $13.967B 53.99
Grifols, S.A (GRFS) Spain $13.118B 16.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.669B 0.00
Neurocrine Biosciences (NBIX) United States $11.423B 44.41
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $8.246B 43.84
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.195B 9.91
United Therapeutics (UTHR) United States $5.170B 11.95
Arrowhead Pharmaceuticals (ARWR) United States $4.517B 493.11
Hypermarcas (HYPMY) Brazil $4.293B 15.79
Evotec AG (EVTCY) Germany $4.065B 109.55
Nektar Therapeutics (NKTR) United States $3.930B 0.00
FibroGen (FGEN) United States $3.780B 0.00
ChemoCentryx (CCXI) United States $3.385B 0.00
PTC Therapeutics (PTCT) United States $3.121B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.504B 12.12
Sage Therapeutics (SAGE) United States $2.410B 0.00
Cronos Group (CRON) Canada $2.376B 67.90
Pacira BioSciences (PCRX) United States $2.312B 47.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.820B 0.00
Xencor (XNCR) United States $1.814B 0.00
Corcept Therapeutics (CORT) United States $1.759B 17.44
USANA Health Sciences (USNA) United States $1.706B 16.08
Indivior (INVVY) United States $1.655B 20.55
Ironwood Pharmaceuticals (IRWD) United States $1.567B 11.99
Heron Therapeutics (HRTX) United States $1.521B 0.00
Akebia Therapeutics (AKBA) United States $1.510B 0.00
Revolution Medicines (RVMD) United States $1.433B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.410B 15.19
Zogenix (ZGNX) United States $1.348B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.256B 0.00
Karyopharm Therapeutics (KPTI) United States $1.233B 0.00
Esperion Therapeutics (ESPR) United States $1.116B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
VAXART, INC (VXRT) United States $1.009B 0.00
Translate Bio (TBIO) United States $0.988B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.941B 42.01
Tilray (TLRY) Canada $0.928B 0.00
Altimmune (ALT) United States $0.872B 0.00
Endo (ENDP) Ireland $0.832B 1.29
BioCryst Pharmaceuticals (BCRX) United States $0.776B 0.00
ImmunoGen (IMGN) United States $0.726B 0.00
Trillium Therapeutics (TRIL) Canada $0.620B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Radius Health (RDUS) United States $0.566B 0.00
Aerie Pharmaceuticals (AERI) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.528B 0.00
Ardelyx (ARDX) United States $0.527B 0.00
Molecular Templates (MTEM) United States $0.526B 0.00
Flexion Therapeutics (FLXN) United States $0.523B 0.00
TherapeuticsMD (TXMD) United States $0.516B 0.00
Innate Pharma SA (IPHYF) France $0.495B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.492B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.472B 18.43
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
DURECT (DRRX) United States $0.460B 0.00
Ocular Therapeutix (OCUL) United States $0.448B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.427B 10.32
Rigel Pharmaceuticals (RIGL) United States $0.410B 0.00
Organogenesis Holdings (ORGO) United States $0.394B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.368B 0.00
Calithera Biosciences (CALA) United States $0.343B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.316B 0.00
IMV INC (IMV) Canada $0.313B 0.00
PROFOUND MEDICL (PROF) Canada $0.304B 0.00
MEI Pharma (MEIP) United States $0.302B 0.00
Harpoon Therapeutics (HARP) United States $0.301B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.282B 0.00
Redhill Biopharma (RDHL) Israel $0.275B 0.00
OptiNose (OPTN) United States $0.262B 0.00
Lannett Co Inc (LCI) United States $0.253B 5.54
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Rafael Holdings (RFL) United States $0.227B 0.00
Nature's Sunshine Products (NATR) United States $0.202B 26.61
Taiwan Liposome (TLC) Taiwan $0.198B 0.00
KalVista Pharmaceuticals (KALV) United States $0.195B 0.00
Nivalis Therapeutics (ALPN) United States $0.195B 0.00
Onconova Therapeutics (ONTX) United States $0.192B 0.00
Aquestive Therapeutics (AQST) United States $0.191B 0.00
Heat Biologics (HTBX) United States $0.176B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 3.89
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.130B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.121B 0.00
Xeris Pharmaceuticals (XERS) United States $0.116B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.111B 0.00
CTI BioPharma (CTIC) United States $0.109B 0.00
Biomerica (BMRA) United States $0.109B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.109B 0.00
Champions Oncology (CSBR) United States $0.108B 0.00
Otonomy (OTIC) United States $0.105B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.105B 0.00
MediWound (MDWD) Israel $0.105B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Recro Pharma (REPH) United States $0.097B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.096B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.093B 0.00
Hemispherx BioPharma (AIM) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.090B 0.00
Aclaris Therapeutics (ACRS) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Lipocine (LPCN) United States $0.082B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
Sundial Growers (SNDL) Canada $0.063B 0.00
PolarityTE (PTE) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 30.90
Addex Therapeutics (ADXN) Switzerland $0.051B 0.00
Novan (NOVN) United States $0.049B 0.00
IsoRay (ISR) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
GTx (ONCT) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.92
AgeX Therapeutics (AGE) United States $0.041B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Jaguar Animal Health (JAGX) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.18
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Can-Fite Biopharma (CANF) Israel $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.29
Regulus Therapeutics (RGLS) United States $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Vical (BBI) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00